Avandia administration for 6-12 weeks

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
265	脂肪萎縮症	1

265. 脂肪萎縮症

臨床試験数 : 112 / 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00006185 (ClinicalTrials.gov)	September 1999	22/8/2000	Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome	Cellular Mechanisms for Metabolic Dysfunction in HIV	HIV Infections;Lipodystrophy;Insulin Resistance	Drug: Avandia administration for 6-12 weeks	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	NULL	Completed	18 Years	55 Years	Both		Phase 1	United States

First Previous1Next Last